Capping Copays Will Raise Premiums, Up Drug Prices

Share this content:
Capping Copays Will Raise Premiums, Up Drug Prices
Capping Copays Will Raise Premiums, Up Drug Prices

THURSDAY, Sept. 29, 2016 (HealthDay News) -- The proposed capping of copays will raise premiums and is likely to increase drug prices, according to a report from the National Center for Policy Analysis (NCPA).

Devon M. Herrick, Ph.D., from the NCPA, discusses the policy of capping copays, which has been proposed by some policymakers. Nearly one-third of states have passed legislation or introduced bills that seek to limit cost-sharing; a federal bill has been proposed that would eliminate all prescription drug cost-sharing for Medicare beneficiaries above the threshold (currently set at $7,500 per year).

Herrick notes that these proposals and laws are not recommended. An estimated $250 monthly cap on out-of-pocket spending on drugs would benefit only about 1 percent of all Americans who take any prescription drug. In addition, nearly half of the benefits associated with a copay cap would go to families earning more than four times the federal poverty level. The copay cap would raise premiums for all policyholders and encourage increases in drug prices.

"The share of prescription costs Americans pay out of pocket has been falling for decades; most prescription drug costs are paid directly by drug plans sponsored by insurers and health plans," Herrick said in a statement. "State and federal proposals to cap drug cost-sharing could actually lead to higher drug prices, higher premiums, and force millions of Americans to pay more, albeit indirectly."

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

Adding HIPEC to Cytoreductive Surgery Beneficial in Ovarian CA

Adding HIPEC to Cytoreductive Surgery Beneficial in Ovarian ...

Longer survival with hyperthermic intraperitoneal chemotherapy in stage III epithelial ovarian cancer

Chaplains Effective in Facilitating Advance Care Planning

Chaplains Effective in Facilitating Advance Care Planning

80 percent of patients who met chaplains in medical practice completed or provided advance directive

Alzheimer's Disease Variants Linked to Brain Amyloidosis

Alzheimer's Disease Variants Linked to Brain Amyloidosis

Significant correlations found for adenosine triphosphate-binding cassette subfamily A member

is free, fast, and customized just for you!

Already a member?

Sign In Now »